Our objective was to assess the test–retest reliability of the Unified Parkinson's Disease Rating
Scale (UPDRS). The UPDRS is the most widely used instrument for measuring severity of …

The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational,
international, multi-center study designed to identify PD progression biomarkers both to improve …

… Dr Siderowf has received consulting fees or honoraria from Boehringer Ingelheim, Merck
Serono, and Teva. Dr Stacy has received consulting fees or honoraria from Allergan, …

Background Aggregated α-synuclein plays an important role in Parkinson’s disease
pathogenesis. Cinpanemab, a human-derived monoclonal antibody that binds to α-synuclein, is …

Importance We observed a significant correlation between cerebrospinal fluid (CSF) levels
of tau proteins and α-synuclein, but not β-amyloid 1-42 (Aβ1-42), and lower concentration of …

Here, we investigated if TAR-DNA-binding protein-43 (TDP-43), the disease protein in
frontotemporal lobar degeneration and ubiquitin inclusions with or without motor neuron disease …

Objective To determine the frequency and correlates of impulse control disorders (ICDs) in
Parkinson disease (PD). Design An unstructured screening interview for ICDs (compulsive …

Objective: To assess factors associated with impulse control disorders (ICDs) in Parkinson
disease (PD) using a multicenter case–control design. Methods: Patients enrolled in the …

OBJECTIVES: To examine Montreal Cognitive Assessment (MoCA) performance in patients
with Parkinson's disease (PD) with “normal” global cognition according to Mini‐Mental State …

As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's
disease (PD) exists, the aim of this study was to design and assess the psychometric …